Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
NCT ID: NCT06421285
Last Updated: 2025-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-01-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study
NCT06459245
Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer
NCT00489125
The Effect of Arm Exercises on Arm Oedema After Breast Cancer Surgery
NCT05303675
Exercise Prehabilitation of Breast Cancer
NCT07240584
Evaluating the Effectiveness of an Early Exercise Program After Breast Reconstruction
NCT06552650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Patients aged 20 or older who were first diagnosed with breast cancer
* Patients scheduled to undergo neoadjuvant chemotherapy before surgery Study design: Prospective randomized controlled comparative clinical study
* Intervention is performed for at least 3 months during the neoadjuvant chemotherapy period before surgery.
* Treatment group: Individually tailored exercise consisting of aerobic, strength, and flexibility exercises is prescribed, self-exercise compliance monitoring through an application, and diet management education through nutritional counseling.
* Control group: One session of flexibility exercise training, diet management education through nutritional counseling
Result variable:
* Primary outcome variable:
1\) Incidence and severity of postoperative lymphedema: bilateral upper limb volume, ICG lymphography
* Secondary outcome variables:
1. Clinical information: Demographic, disease and treatment-related data
2. Physical-related: height/weight/waist circumference measurement, body composition test, physical examination (axillary membrane evaluation)
3. Upper extremity function (shortening of the pectoralis major muscle, adhesive capsulitis): evaluation of shoulder range of motion, upper extremity muscle strength/grip strength
4. Quality of life assessment: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30(EORTC QLQ-C30), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Breast cancer module 23(EORTC QLQ-BR23)
Assessment Schedule:
* Initial treatment and evaluation: Immediately after breast cancer diagnosis
* Follow-up evaluation: Immediately after completion of exercise intervention (preoperatively), and at 1, 3, and 6 months postoperatively.
Number of study subjects:
* This study will be conducted as a preliminary study for future research, and will be conducted on a total of 60 patients (30 in the experimental group and 30 in the control group) with an allocation ratio between groups of 1:1.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Control group
SUPPORTIVE_CARE
SINGLE
* Patients scheduled to undergo neoadjuvant chemotherapy before surgery
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Individually tailored exercise consisting of aerobic, strength, and flexibility exercises is prescribed, self-exercise compliance monitoring through an application, and diet management education through nutritional counseling.
Aerobic exercise, Strength training, Flexibility exercise
Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement
* Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise
* Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation
Control group
One session of flexibility exercise education, diet management education through nutritional counseling
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic exercise, Strength training, Flexibility exercise
Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement
* Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise
* Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for surgery and starting neoadjuvant chemotherapy before surgery
Exclusion Criteria
20 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jae Yong Jeon, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaeyong Jeon
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Heejeong Kim
Role: STUDY_CHAIR
Asan Medical Center
Seungwoo Cha
Role: STUDY_CHAIR
Asan Medical Center
Chul Jung
Role: STUDY_CHAIR
Asan Medical Center
Hwayeong Cheon
Role: STUDY_CHAIR
Asan Medical Center
Junghwa Do
Role: STUDY_CHAIR
Asan Medical Center
Woojin Jeong
Role: STUDY_CHAIR
Asan Medical Center
Doyoung Kim
Role: STUDY_CHAIR
Asan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul Asan Medical Center
Seoul, Seoul Special City, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-0255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.